| Generic Name | Composition | Presentation | Type |
| Sodium Cromoglycate 2% | Sodium Cromoglycate IP 2% w/v Benzalkonium Chloride (As Preservative) 0.01% w/v Sterile Aqueous Base q.s. |
Available in plastic bottle of 5 ml. | Ophthalmic Solution |
| Sodium Cromoglycate 4% | Each 5 ml Vial contains Sodium Cromoglycate IP 4% w/v Benzalkonium Chloride N.F. 0.01% (as preservative) 0.01% w/v I Sterile Aqueous Base q.s |
Available in sterile plastic bottle of 5ml. | Ophthalmic Suspension (Eye Drops) |
| Chlorpheniramine Maleate + Phenylephrine | Chlorpheniramine Maleate I.P 0. 2% Phenylephrine Hydrochloride I.P. 0.12% Antipyrin B.P 0.1% Chlorbutol (As preservative) I.P 0.5% Aqueous Base q.s. |
Available in sterile glass bottle of 5 ml. | Ophthalmic Solution (Eye Drops) |
| Olopatadine 0.1% | Olopatadine Hydrochloride 1.11 mg Equivalent to Olopatadine 1.0 mg Benzalkonium Chloride N.F. 0.01% (as preservative) Sterile Aqueous Vehicle q.s |
Available in 5 ml. plastic bottle. | Ophthalmic Solution (Eye Drops) |
| Olopatadine 0.2% | |||
| Naphazoline + Chlorpheniramine Maleate + Zn S + HPMC | Naphazoline HCL U.S.P. 0.056% w\v Hydrxtpropylmethyl cellulose IP 0.006 % w/v Chlorpheniramine Maleate IP 0.01% w\v Zinc Sulphate IP 0.12% w\v Boric Acid IP 1.25% w\v Sodium Chloride IP 0.05% w\v Chlorbutol IP 0.35% w\v (as preservative) Aqueous Vehicle q.s |
Available in sterile plastic bottle of 5ml. | Ophthalmic Solution (Eye Drops) |